Overview and Scope
Lab automation in drug discovery refers to the use of advanced technologies and
robotics to streamline and optimize laboratory processes related to new drug
development and research. It is used to significantly enhance the speed and
success rate of drug discovery efforts by automating repetitive tasks and
integrating advanced instruments and software.
Sizing and Forecast
The lab automation in drug discovery market size has grown strongly in recent
years. It will grow from $6.13 billion in 2023 to $6.47 billion in 2024 at a
compound annual growth rate (CAGR) of 5.6%.
The growth in the historic period can be attributed to the increasing
complexity of drug discovery, demand for efficiency and cost reduction, growing
need for high-throughput screening, rising labor costs, and pressure to
accelerate drug development timelines.
The lab automation in drug discovery market size is expected to see strong
growth in the next few years. It will grow to $7.96 billion in 2028 at a
compound annual growth rate (CAGR) of 5.3%.
The growth in the forecast period can be attributed to expanding drug
pipelines of pharmaceutical companies, rise in personalized medicine and
precision therapeutics, increasing focus on rare diseases and orphan drugs,
demand for remote and decentralized clinical trials, the emergence of
microfluidics and lab-on-a-chip technologies. Major trends in the forecast
period include proliferation of modular and customizable automation solutions,
adoption of cloud-based platforms for data management and collaboration, growth
of automation in emerging markets, rise of virtual drug discovery companies
leveraging automation and digital technologies, development of standardized
protocols and interoperable systems.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/lab-automation-in-drug-discovery-global-market-report
Segmentation & Regional Insights
The lab automation in drug discovery market covered in this report is segmented
–
1) By Type: Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms,
Automated Storage And Retrieval Systems, Other Types
2) By Component: Instruments, Software, Services
3) By Application: High-Throughput Screening, Compound Management, Sample
Preparation, Other Applications
4) By End-User: Biotechnology And Pharmaceutical Industries, Research
Institutes, Other End-Users
North America was the largest region in the lab automation in drug discovery
market in 2023. Asia-Pacific is expected to be the fastest-growing region in
the forecast period. The regions covered in the lab automation in drug
discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North
America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the
report:
https://www.thebusinessresearchcompany.com/sample_request?id=14410&type=smp
Major Driver Impacting Market Growth
The increasing demand for precision medicine is expected to propel the growth
of lab automation in the drug discovery market going forward. Precision
medicine, also known as personalized medicine, is an approach to medical
treatment and prevention that takes into account individual variability in
genes, environment, and lifestyle for each person. Lab automation
accelerates research, improves experimental repeatability, and improves
the efficiency of precision medicine and drug discovery procedures, ultimately
leading to the creation of more effective medicines and diagnostics suited to
individual patients. For instance, in October 2022, according to the
Personalized Medicine Coalition (PMC), a US-based organization that promotes
understanding and adoption of personalized medicine, more than 75,000 genetic
testing products and 300 personalized medicines will be on the market for
people with multiple types of cancer, genetic rare diseases, and a range of
chronic and infectious diseases. Therefore, the increasing demand for precision
medicine is driving the growth of lab automation in the drug discovery market.
Key Industry Players
Major companies operating in the lab automation in drug discovery market are
Thermo Fisher Scientific Inc., Abbott Diagnostics, Roche Holdings Inc., Beckman
Coulter, Siemens Healthineers, Becton Dickinson and Company, Agilent
Technologies Inc., PerkinElmer Inc., Endress+Hauser, Shimadzu Corporation,
Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN, Beckhoff Automation GmbH
& Co. KG, Eppendorf AG, Tecan Group Ltd., Brooks Automation Inc., Hamilton
Company, AbCellera Biologics Inc., Hudson Robotics Inc., OpenTrons Labworks
Inc., Quanterix Corporation, The Technology Partnership, HighRes Biosolutions
Inc., Biosero Inc., Peak Analysis and Automation Ltd., Aurora Biomed Inc.,
Arctoris, Inveox GmbH, Synthace, Synchron Lab Automation
The lab automation in drug discovery market report table of contents includes:
1. Executive Summary
2. Lab
Automation In Drug Discovery Market Characteristics
3. Lab
Automation In Drug Discovery Market Trends And Strategies
4. Lab
Automation In Drug Discovery Market - Macro Economic Scenario
5. Global
Lab Automation In Drug Discovery Market Size and Growth
.
32. Global
Lab Automation In Drug Discovery Market Competitive Benchmarking
33. Global
Lab Automation In Drug Discovery Market Competitive Dashboard
34. Key
Mergers And Acquisitions In The Lab Automation In Drug Discovery Market
35. Lab
Automation In Drug Discovery Market Future Outlook and Potential Analysis
36.
Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model:
https://www.thebusinessresearchcompany.com/global-market-model
No comments:
Post a Comment